Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin in Ureteric Stones Treated With ESWL
2005-005481-36Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in ureterolithiasis, sponsored by Sanofi. Started Mar 2006; status: terminated.
02
Drugs
alfuzosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on 2005-005481-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005481-36.